Publicaciones en colaboración con investigadores/as de Hospital Universitario de Guadalajara (201)

2026

  1. A Pediatric Rash Beyond Childhood

    Actas Dermo-Sifiliograficas, Vol. 117, Núm. 6

  2. Antiretroviral treatment in people living with HIV with late diagnosis initiating ART with DTG/3TC or BIC/TAF/FTC: A real-world cohort analysis

    HIV Medicine, Vol. 27, Núm. 1, pp. 96-105

  3. Biomarkers for Recurrence and Prognosis in Metastatic Urothelial Cancer: Emerging Clinical Applications

    Journal of Cancer, Vol. 17, Núm. 1, pp. 21-31

  4. Clinical Benefits of Tezepelumab in a Real-World Cohort of Patients With Severe Uncontrolled Asthma in Castilla-La Mancha, Spain

    Open Respiratory Archives, Vol. 8, Núm. 3

  5. Clinical Factors Associated With Current Relevance in Allergic Contact Dermatitis: Development of Predictive Models Based on Data From the Spanish Contact Dermatitis Register (REIDAC)

    Contact Dermatitis, Vol. 94, Núm. 6, pp. 614-623

  6. Clinical outcomes of long-acting cabotegravir and rilpivirine in people with HIV aged 60 and older: Real-world data from the Spanish RELATIVITY cohort

    HIV Medicine, Vol. 27, Núm. 1, pp. 58-73

  7. Comparable Inflammatory and Metabolic Outcomes after Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Continuing Dolutegravir/Lamivudine in Virologically Suppressed Adults with HIV (INSTINCT/GESIDA10918 Study)

    Clinical Infectious Diseases, Vol. 82, Núm. 2, pp. e262-e274

  8. Contact Sensitization in Patients With Frontal Fibrosing Alopecia: Patch Test Results With an Extended Baseline Series in Consecutive Patients

    Contact Dermatitis

  9. Determinants of long-acting cabotegravir plus rilpivirine discontinuation in real-world HIV care: insights from the RELATIVITY cohort

    AIDS, Vol. Publish Ahead of Print

  10. Effectiveness and Persistence of Long-Acting Injectable Cabotegravir and Rilpivirine in Migrant Individuals Living With HIV in Spain: Substudy of the RELATIVITY Cohort

    Journal of the International AIDS Society, Vol. 29, Núm. 4

  11. Effectiveness of a Comprehensive Program Including a Novel Concentrated High-Protein, High-Calorie Oral Nutritional Supplement to Enhance Nutritional and Morphofunctional Recovery in Malnourished Patients with Cancer: The ONAVIDA Study

    Nutrients , Vol. 18, Núm. 9

  12. Epidemiological, Clinical and Allergic Profile of Patients With Dyshidrotic Eczema (Acute and Recurrent Vesicular Dermatitis): Evaluation of the Spanish Registry of Research in Contact Dermatitis and Cutaneous Allergy (REIDAC)

    Contact Dermatitis

  13. From Classical to Emerging Biomarkers of Brain and Central Nervous System Tumors. An Evidence-Based Review with a Focus on Gliomas

    Cellular and Molecular Neurobiology, Vol. 46, Núm. 1

  14. Genotyping not required for sustained effectiveness of long-acting cabotegravir plus rilpivirine: evidence from the RELATIVITY cohort

    AIDS (London, England), Vol. 40, Núm. 4, pp. 414-427

  15. Impact of Sleep-disordered Breathing Management in Primary Care on Systemic Hypertension Control: Protocol for the METASLEEP Implementation Trial

    Open Respiratory Archives, Vol. 8, Núm. 1

  16. Learning curves and training thresholds for paediatricians performing neonatal hip ultrasound using the Graf method in a universal screening program

    European Journal of Pediatrics, Vol. 185, Núm. 4

  17. Long-acting cabotegravir and rilpivirine in people with HIV and obesity: Real-world outcomes from the RELATIVITY cohort

    HIV Medicine, Vol. 27, Núm. 5, pp. 690-709

  18. Longitudinal changes in circulating biomarkers from baseline to week 48 in treatment-Naïve people living with HIV initiating integrase inhibitor-based antiretroviral therapy

    PLOS ONE, Vol. 21, Núm. 2 February

  19. Nocturnal blood pressure patterns in pediatric obstructive sleep apnea: The Kids Trial study

    Sleep Medicine, Vol. 144

  20. Peak Inspiratory Flow Capability for Simulated Dry Powder Inhaler Resistances in Asthma Patients Prescribed Pressurized Metered-Dose Inhalers with Valved Holding Chambers: The USE-DPI Study

    Journal of Clinical Medicine, Vol. 15, Núm. 8